CTRI/2020/02/023206尚未招募未知
Prospective analysis of role of PSMA PET-CT in evaluation of Hepatocellular Carcinoma patients at Army Hospital R & R, Delhi: A pilot study
Abhishek Mahato0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients of HCC being evaluated and treated at Army Hospital Research and Referral New Delhi
排除标准
- •Pregnant ladies
研究者
相似试验
招募中
不适用
PET scan for measuring response in lymphoma of braiCTRI/2021/05/033776Tata Memorial Centre Mumbai
招募中
不适用
Evaluation of the use of PET/CT in Adenoid Cystic Carcinoma (ADC)Adenoid Cystic CarcinomaRBR-84nmnm9Eduardo Nóbrega Pereira Lima
进行中（未招募）
1 期
Interest of PET-PSMA Imaging potentialised by androgen blockade in localized prostatic adenocarcinoma in relapse or reccurent diseaseEUCTR2019-003346-32-FRCentre Léon Bérard52
Unknown
不适用
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageProstate CancerNCT04116086Sheba Medical Center50
进行中（未招募）
1 期
Prospective evaluation of 68Ga-PSMA PET-CT for Recurrence detection of Prostate Cancer and its impact on patient management. The ProsPERo TrialMales 18 years of age or older with histologically-proven prostate adenocarcinoma and biochemical relapse with rising PSA level after initial treatment with radical curative intent, not yet on palliative systemic treatment and considered for further salvage therapyMedDRA version: 19.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10068979Term: Imaging procedureSystem Organ Class: 10022891 - InvestigationsEUCTR2016-000842-79-BEInstitut Jules Bordet75